SCHEMBL28211105

SCHEMBL28211105

CCC(=O)c1ccc(-c2ccsc2)c(N)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ USP2 O75604 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ CHEK2 O96017 8/20 0.43
▸ ADORA3 P0DMS8 2/20 0.43
▸ ADORA2A P29274 2/20 0.43
▸ ADORA2B P29275 2/20 0.43
▸ ADORA1 P30542 2/20 0.43
▸ IKBKB O14920 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ CHEK1 O14757 1/20 0.40
▸ HDAC1 Q13547 1/20 0.39
▸ MMP2 P08253 1/20 0.39
▸ MMP9 P14780 1/20 0.39
▸ MMP8 P22894 1/20 0.39
▸ CYP2A6 P11509 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18458312 0.84 CHEK2 (0.46) MAPTMEN1USP2ALOX15KMT2A
SCHEMBL11539387 0.79 MAPT (0.59) MAPTMEN1USP2KMT2AHSD17B10
SCHEMBL28211106 0.79 ERN1 (0.41) MAPTKMT2AADORA3ADORA2AADORA2B
SCHEMBL12670300 0.77 SMN1; SMN2 (0.59) MAPTCHEK2ADORA3ADORA2AADORA2B
SCHEMBL18458070 0.73 IDH2 (0.53) MEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL10740176 0.72 ATM (0.49) MAPTMEN1USP2KMT2AHSD17B10
SCHEMBL18458314 0.72 KCNH2 (0.41) MAPTMEN1USP2ALOX15KMT2A
SCHEMBL692248 0.71 IMPDH2 (0.54) MAPTMEN1USP2ALOX15KMT2A
SCHEMBL4876161 0.70 — —
SCHEMBL34467254 0.70 KCNH2 (0.57) MAPTMEN1USP2ALOX15KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107922375-A Target the antitumoral compounds and its application method of IDH2 mutation 正大天晴药业集团股份有限公司 2018-04-17 — — CN disclosed
Send feedback